Screening In-Depth Focus 2017
In this In-Depth Focus on Screening, we look at clinically-oriented phenotypic screening and explore how 3-D bioprinted tissues can be used as disease-in-a-dish models for drug screening.
List view / Grid view
In this In-Depth Focus on Screening, we look at clinically-oriented phenotypic screening and explore how 3-D bioprinted tissues can be used as disease-in-a-dish models for drug screening.
Flow cytometry has become a widely used technology in life science research. It is also essential for many pharma and biotechnology companies due to its proficiency in identifying biomarkers, developing biopharmaceuticals, and assessing the efficiency of new pharmacological protocols...
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
The first data network for this research could also be the blueprint for similar data networks for research into other conditions...
Elsevier has announced that applications and nominations for The Hive, its innovation hub for biotech and pharmaceutical startups, are now open.
Scientists at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have succeeded in revealing a key mechanism of membrane deformation.
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
BioGeneration Ventures (BGV) announces an investment by the European Investment Fund (EIF) and other new investors in BGV III...
Water is the most essential resource of life, but it's also something of a mystery due to its unique solvation characteristics - how things dissolve in it.
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.
For characterising higher order protein structure and accurately defining CQAs of biopharmaceuticals...
This week a new collaborative European project is being launched that aims to re-invigorate the way that research into life sciences and biomedicine is organised and funded. The project, named ORION, will be coordinated by The Centre for Genomic Regulation in Barcelona, Spain, who is one of nine partners taking…
Drug developers sometimes think of imaging as an emerging discipline. But John Waterton, Paul Hockings, Juliana Maynard and Caleb Roberts explain how imaging biomarkers are transforming drug development. Francesco Gatto and Jens Nielsen, from the Chalmers University of Technology in Sweden, discuss moving towards systems biomarkers for cancer diagnosis...
Sanofi and Lonza have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
Orion and Finland are both celebrating their centenaries in 2017.